A meta-analysis of the utility of C-reactive protein, erythrocyte sedimentation rate, fecal calprotectin, and fecal lactoferrin to exclude inflammatory bowel disease in …

SB Menees, C Powell, J Kurlander… - Official journal of the …, 2015 - journals.lww.com
Objectives: Irritable bowel syndrome (IBS) is viewed as a diagnosis of exclusion by most
providers. The aim of our study was to perform a systematic review and meta-analysis to …

[HTML][HTML] Faecal calprotectin

WPNGW Pathirana, SAP Chubb, MJ Gillett… - The Clinical …, 2018 - ncbi.nlm.nih.gov
Calprotectin is a calcium-and zinc-binding protein of the S-100 protein family which is mainly
found within neutrophils and throughout the human body. The presence of calprotectin in …

The role and utility of faecal markers in inflammatory bowel disease

FS Lehmann, E Burri… - Therapeutic advances in …, 2015 - journals.sagepub.com
Crohn's disease and ulcerative colitis are characterized by periods of symptomatic relapse
and remission. Diagnosis and assessment of inflammatory bowel disease has so far been …

A new rapid test for fecal calprotectin predicts endoscopic remission and postoperative recurrence in Crohn's disease

T Lobatón, A López-García… - Journal of Crohn's …, 2013 - academic.oup.com
Abstract Introduction: Fecal calprotectin (FC), as determined by the enzyme-linked
immunoassay (ELISA) test, has been proposed as a promising biomarker of endoscopic …

International consensus on methodological issues in standardization of fecal calprotectin measurement in inflammatory bowel diseases

F d'Amico, DT Rubin, PG Kotze, F Magro… - UEG …, 2021 - Wiley Online Library
Background Fecal calprotectin (FC) is a non‐invasive marker of gut inflammation which is
frequently used to guide therapeutic decisions in patients with inflammatory bowel diseases …

A new rapid quantitative test for fecal calprotectin predicts endoscopic activity in ulcerative colitis

T Lobatón, F Rodríguez-Moranta… - Inflammatory bowel …, 2013 - academic.oup.com
Background Fecal calprotectin (FC) determined by the enzyme-linked immunosorbent assay
(ELISA) test has been proposed as a promising biomarker of endoscopic activity in …

Oral manifestations of inflammatory bowel disease and the role of non-invasive surrogate markers of disease activity

DG Ribaldone, S Brigo, M Mangia, GM Saracco… - Medicines, 2020 - mdpi.com
Inflammatory bowel disease (IBD), which includes Crohn's disease (CD) and ulcerative
colitis (UC), can be associated with several extra-intestinal manifestations requiring a …

[HTML][HTML] Diagnostic utility of faecal biomarkers in patients with irritable bowel syndrome

J Däbritz, J Musci, D Foell - World journal of gastroenterology: WJG, 2014 - ncbi.nlm.nih.gov
Irritable bowel syndrome (IBS) is a common functional gastrointestinal (GI) disorder
characterized by unspecific symptoms. In clinical practice it is crucial to distinguish between …

[HTML][HTML] Utility of faecal calprotectin analysis in adult inflammatory bowel disease

LA Smith, DR Gaya - World journal of gastroenterology: WJG, 2012 - ncbi.nlm.nih.gov
The inflammatory bowel diseases (IBD), Crohn's disease and ulcerative colitis, are chronic
relapsing, remitting disorders. Diagnosis, along with assessment of disease activity and …

[HTML][HTML] Measurement of calprotectin in ascitic fluid to identify elevated polymorphonuclear cell count

E Burri, F Schulte, J Muser, R Meier… - World Journal of …, 2013 - ncbi.nlm.nih.gov
AIM: To evaluate the diagnostic capability of calprotectin in ascitic fluid for detecting a
polymorphonuclear (PMN) cell count> 250/μL ascites. METHODS: In this prospective …